← Abivax S.A.
| Annual Trend | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| Operating Revenue | — | $0 | $0 | $0 | $0 | $0 | |
| Revenue From Interest | — | $0 | $2.4m | $8.2m | $5.6m | — | |
| Cost Of Revenue | $45.5m |
$50.8m
+11.53%
|
$107.4m
+111.58%
|
$148.3m
+38.06%
|
$184.0m
+24.08%
|
— | |
| Reconciled Cost Of Revenue | $45.5m |
$50.5m
+11.00%
|
— | — | — | — | |
| Gross Profit (derived) | ($45.5m) |
($50.8m)
-11.53%
|
($105.0m)
-106.81%
|
($140.0m)
-33.39%
|
($178.4m)
-27.38%
|
— | |
| Net Interest Income | — | ($5.3m) |
($9.5m)
-80.42%
|
($5.9m)
+37.63%
|
($52.5m)
-784.94%
|
($46.7m)
+10.98%
|
|
| Research and development | ($47.8m) | $48.3m | $103.2m | $146.5m | $177.8m | $188.0m | |
| Sales and marketing | $0 | $0 | ($6.4m) | ($6.0m) | ($5.2m) | — | |
| Selling And Marketing Expense | — | $0 | $709k | $932k | $224k | $72.0m | |
| General and administrative | ($5.6m) | $7.5m | $22.4m | $32.9m | $67.7m | $71.9m | |
| General And Administrative Expense | — | $7.5m | $28.1m | $38.0m | $72.6m | $71.9m | |
| Restructuring And Mergern Acquisition | $0 | ($1.4m) | ($3.2m) | $1.4m | — | $1.4m | |
| Operating expenses: | |||||||
| Other Operating Expenses | — | ($4.6m) | ($4.6m) | ($12.4m) | ($4.6m) | — | |
| Total operating expenses | ($53.4m) | ($69.4m) | ($132.0m) | ($185.4m) | ($250.6m) | $255.1m | |
| Other operating income | ($41.4m) | ($64.8m) | ($127.4m) | ($173.0m) | ($246.1m) | — | |
| Other Non Operating Income Expenses | — | $1.4m | $3.2m | ($1.4m) | — | — | |
| Interest Expense On Lease Liabilities | — | $10k | $13k | $61k | $64k | $26.5m | |
| Interest Expense | — | $6.9m | $13.8m | $12.4m | $28.5m | $26.5m | |
| Interest Income | — | $0 | $2.8m | $9.0m | $5.8m | $5.4m | |
| Net Non Operating Interest Income Expense | — | ($5.3m) | ($9.5m) | ($5.9m) | ($52.5m) | ($46.7m) | |
| Financial gain (loss) | ($1.1m) | $4.1m | ($20.4m) | ($3.3m) | ($84.2m) | — | |
| Gain On Sale Of Security | — | $9.4m | ($7.6m) | $2.7m | ($27.9m) | ($20.5m) | |
| Other Income | — | $4.6m | $4.6m | $12.4m | $4.6m | — | |
| Other Income Expense | — | ($4.3m) | ($10.9m) | $2.7m | ($31.7m) | ($24.3m) | |
| Pre-Tax Income | ($42.5m) | ($60.7m) | ($147.7m) | ($176.2m) | ($330.3m) | ($326.1m) | |
| Income tax | $0 | $0 | $0 | $0 | ($5.8m) | $6.1m | |
| Net loss before tax | ($42.5m) | ($60.7m) | ($147.7m) | ($176.2m) | ($330.3m) | — | |
| Net loss for the period | ($42.5m) | ($60.7m) | ($147.7m) | ($176.2m) | ($336.1m) | — | |
| Net Income From Continuing And Discontinued Operation | ($42.5m) | ($60.7m) | ($147.7m) | ($176.2m) | ($336.1m) | ($332.2m) | |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | — | — | — | |
| Basic Earnings (Loss) Per Share | ($2.75) | ($3.18) | ($3.43) | ($2.80) | ($4.83) | ($4.61) | |
| Diluted Earnings (Loss) Per Share | ($2.75) | ($3.18) | ($3.43) | ($2.80) | ($4.83) | ($4.61) | |
| Basic Average Shares | — | $19.1m | $43.1m | $63.3m | $69.5m | $73.4m | |
| Diluted Average Shares | — | $19.1m | $43.1m | $63.3m | $69.5m | $73.4m | |
| Additional Financial Items | |||||||
| Applicable Tax Rate | — | — | — | $0 | $0 | — | |
| Finance Income | $2.5m | $11.1m | $7.5m | $13.7m | $27.5m | — | |
| Profit Loss Before Tax | ($42.5m) | ($60.7m) | ($147.7m) | ($176.2m) | ($330.3m) | — | |
| Profit Loss From Operating Activities | ($41.4m) | ($64.8m) | ($127.4m) | ($173.0m) | ($246.1m) | — | |
| Financial income | $2.5m | $11.1m | $7.5m | $13.7m | $27.5m | — | |
| Depreciation Amortization Depletion Income Statement | $156k | $71k | — | — | — | — | |
| Depreciation And Amortization In Income Statement | $156k | $71k | — | — | — | — | |
| Depreciation Income Statement | $156k | $71k | — | — | — | — | |
| Diluted EPS | — | ($3.18) | ($3.43) | ($2.78) | ($4.83) | ($4.61) | |
| Diluted NI Availto Com Stockholders | ($42.5m) | ($60.7m) | ($147.7m) | ($176.2m) | ($336.1m) | ($332.2m) | |
| Impairment Of Capital Assets | $0 | $13.6m | $0 | $0 | — | $0 | |
| Normalized EBITDA | — | ($49.0m) | ($122.4m) | ($165.4m) | ($269.0m) | ($298.5m) | |
| Normalized Income | — | ($56.5m) | ($136.9m) | ($178.9m) | ($312.3m) | ($317.6m) | |
| Other Gand A | — | $6.1m | $13.3m | $16.2m | $16.5m | — | |
| Other Special Charges | ($125k) | $13.9m | $3.2m | — | $3.8m | — | |
| Other Taxes | $116k | $44k | — | — | — | — | |
| Reconciled Depreciation | — | $485k | $707k | $1.1m | $1.1m | $1.2m | |
| Rent And Landing Fees | $548k | $1.0m | — | — | — | $482k | |
| Salaries And Wages | — | $1.4m | $14.8m | $21.8m | $56.2m | $53.3m | |
| Selling General And Administration | — | $7.5m | $28.8m | $38.9m | $72.9m | — | |
| Special Income Charges | — | ($13.6m) | ($3.2m) | $0 | ($3.8m) | $71k | |
| Tax Effect Of Unusual Items | — | $0 | $0 | $0 | ($7.9m) | ($9.7m) | |
| Tax Provision | — | $0 | $0 | $0 | $5.8m | $6.1m | |
| Tax Rate For Calcs | — | $0 | $0 | $0 | $0 | $0 | |
| Finance Costs | — | $7.0m | $27.9m | $17.0m | $111.7m | — | |
| Other Finance Cost | — | $83k | $73k | $64k | $29k | — | |
| Financial expenses | ($3.6m) | ($7.0m) | ($27.9m) | ($17.0m) | ($111.7m) | — | |
| Operating Expense | — | $51.2m | $127.4m | $173.0m | $246.1m | $255.1m | |
| Rent Expense Supplemental | $548k | $1.0m | — | — | — | $482k | |
| Total Unusual Items | — | ($4.3m) | ($10.9m) | $2.7m | ($31.7m) | ($24.3m) | |
| Total Expenses | — | $51.2m | $127.4m | $173.0m | $246.1m | $255.1m | |
| Total Other Finance Cost | — | ($1.7m) | ($1.5m) | $2.5m | $29.8m | $25.7m |